PortalPublikationenMechanical circulatory support devices in cardiogenic shock ...

Mechanical circulatory support devices in cardiogenic shock and acute heart failure: current evidence

Standard

Mechanical circulatory support devices in cardiogenic shock and acute heart failure: current evidence. / Schrage, Benedikt; Westermann, Dirk.

in: CURR OPIN CRIT CARE, Jahrgang 25, Nr. 4, 08.2019, S. 391-396.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Schrage, B & Westermann, D 2019, 'Mechanical circulatory support devices in cardiogenic shock and acute heart failure: current evidence', CURR OPIN CRIT CARE, Jg. 25, Nr. 4, S. 391-396. https://doi.org/10.1097/MCC.0000000000000629

APA

Schrage, B., & Westermann, D. (2019). Mechanical circulatory support devices in cardiogenic shock and acute heart failure: current evidence. CURR OPIN CRIT CARE, 25(4), 391-396. https://doi.org/10.1097/MCC.0000000000000629

Vancouver

Schrage B, Westermann D. Mechanical circulatory support devices in cardiogenic shock and acute heart failure: current evidence. CURR OPIN CRIT CARE. 2019 Aug;25(4):391-396. https://doi.org/10.1097/MCC.0000000000000629

Bibtex

@article{c0dd33fb004b41638864c14b13478167,
title = "Mechanical circulatory support devices in cardiogenic shock and acute heart failure: current evidence",
abstract = "PURPOSE OF REVIEW: The main purpose of this review is to highlight and summarize recently published studies on the usage of short-term mechanical circulatory support devices for treatment of cardiogenic shock. Importantly, this review will focus on percutaneously implanted devices.RECENT FINDINGS: In recent years, usage of active mechanical circulatory support devices, such as catheter-based left ventricular-assist devices and veno-arterial extracorporeal membrane oxygenation devices, has been widely adopted. Several device-specific strategies have been proposed to improve outcome of treated patients with cardiogenic shock, ranging from early identification and treatment of patients via dedicated shock protocols to combinatory usage of these devices. However, this is not supported by prospective, randomized trials but by retrospective analysis, which are significantly impacted by bias.SUMMARY: Randomized, controlled trials are utterly needed to guide treatment with mechanical circulatory support for patients with cardiogenic shock. Importantly, such trials should focus patient selection criteria.",
keywords = "Heart Failure/therapy, Heart-Assist Devices, Humans, Retrospective Studies, Shock, Cardiogenic/therapy",
author = "Benedikt Schrage and Dirk Westermann",
year = "2019",
month = aug,
doi = "10.1097/MCC.0000000000000629",
language = "English",
volume = "25",
pages = "391--396",
journal = "CURR OPIN CRIT CARE",
issn = "1070-5295",
publisher = "LIPPINCOTT WILLIAMS & WILKINS",
number = "4",

}

RIS

TY - JOUR

T1 - Mechanical circulatory support devices in cardiogenic shock and acute heart failure: current evidence

AU - Schrage, Benedikt

AU - Westermann, Dirk

PY - 2019/8

Y1 - 2019/8

N2 - PURPOSE OF REVIEW: The main purpose of this review is to highlight and summarize recently published studies on the usage of short-term mechanical circulatory support devices for treatment of cardiogenic shock. Importantly, this review will focus on percutaneously implanted devices.RECENT FINDINGS: In recent years, usage of active mechanical circulatory support devices, such as catheter-based left ventricular-assist devices and veno-arterial extracorporeal membrane oxygenation devices, has been widely adopted. Several device-specific strategies have been proposed to improve outcome of treated patients with cardiogenic shock, ranging from early identification and treatment of patients via dedicated shock protocols to combinatory usage of these devices. However, this is not supported by prospective, randomized trials but by retrospective analysis, which are significantly impacted by bias.SUMMARY: Randomized, controlled trials are utterly needed to guide treatment with mechanical circulatory support for patients with cardiogenic shock. Importantly, such trials should focus patient selection criteria.

AB - PURPOSE OF REVIEW: The main purpose of this review is to highlight and summarize recently published studies on the usage of short-term mechanical circulatory support devices for treatment of cardiogenic shock. Importantly, this review will focus on percutaneously implanted devices.RECENT FINDINGS: In recent years, usage of active mechanical circulatory support devices, such as catheter-based left ventricular-assist devices and veno-arterial extracorporeal membrane oxygenation devices, has been widely adopted. Several device-specific strategies have been proposed to improve outcome of treated patients with cardiogenic shock, ranging from early identification and treatment of patients via dedicated shock protocols to combinatory usage of these devices. However, this is not supported by prospective, randomized trials but by retrospective analysis, which are significantly impacted by bias.SUMMARY: Randomized, controlled trials are utterly needed to guide treatment with mechanical circulatory support for patients with cardiogenic shock. Importantly, such trials should focus patient selection criteria.

KW - Heart Failure/therapy

KW - Heart-Assist Devices

KW - Humans

KW - Retrospective Studies

KW - Shock, Cardiogenic/therapy

U2 - 10.1097/MCC.0000000000000629

DO - 10.1097/MCC.0000000000000629

M3 - SCORING: Review article

C2 - 31135393

VL - 25

SP - 391

EP - 396

JO - CURR OPIN CRIT CARE

JF - CURR OPIN CRIT CARE

SN - 1070-5295

IS - 4

ER -